Ocugen (OCGN) Operating Margin (2014 - 2026)
Ocugen (OCGN) posted Operating Margin of 1163.67% for Q1 2026, down 113.21% on a QoQ basis from 8805.7% in Q4 2025, and down 18453.0% year-over-year from N/an in Q1 2025.
Ocugen (OCGN) Operating Margin (2014 - 2026) Analysis & Trends
Ocugen's Operating Margin history runs 7 years deep, the most recent figure standing at 1163.67% for Q1 2026.
- Quarterly Operating Margin fell 18453.0% year-over-year to 1163.67% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1483.85% (down 22242.0% YoY) and the FY2025 annual result came in at 1425.7%, down 7534.0% from the prior year.
- Operating Margin was 1163.67% for Q1 2026 at Ocugen, down from 8805.7% in the prior quarter.
- Across five years, Operating Margin topped out at 8805.7% in Q4 2025 and bottomed at 5388.41% in Q3 2022.
- A 5-year average of 1539.43% and a median of 1204.73% in 2024 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2023 — Operating Margin slumped 149809 bps — and 2025, when it surged 1061722 bps.
- Ocugen's Operating Margin stood at 2657.0% in 2022, then jumped by 69 bps to 817.96% in 2023, then slumped by 121 bps to 1811.52% in 2024, then surged by 586 bps to 8805.7% in 2025, then tumbled by 113 bps to 1163.67% in 2026.
- Business Quant data shows OCGN's Operating Margin at 1163.67% in Q1 2026, 8805.7% in Q4 2025, and 1005.99% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | -1,163.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,163.67% |
| Dec 31, 2025 | 8,805.70% |
| Sep 30, 2025 | -1,005.99% |
| Jun 30, 2025 | -1,004.73% |
| Mar 31, 2025 | -979.14% |
| Dec 31, 2024 | -1,811.52% |
| Sep 30, 2024 | -1,166.55% |
| Jun 30, 2024 | -1,353.99% |
| Mar 31, 2024 | -1,204.73% |
| Dec 31, 2023 | -817.96% |
| Sep 30, 2023 | -336.06% |
| Jun 30, 2023 | -4,853.61% |
| Mar 31, 2023 | -4,071.11% |
| Dec 31, 2022 | -2,657.00% |
| Sep 30, 2022 | -5,388.41% |
| Jun 30, 2022 | -3,355.52% |
| Mar 31, 2022 | -3,806.00% |
| Jun 30, 2020 | -7,827.91% |
| Sep 30, 2014 | -4.98% |